Clinical Management of Patients with CABOMETYX® (cabozantinib) + OPDIVO® (nivolumab)

Exelixis
September 14, 2021
 

If you are interested in learning more about CABOMETYX® (cabozantinib) + OPDIVO® (nivolumab), please join our educational presentation: Clinical Management of Patients with CABOMETYX® (cabozantinib) + OPDIVO® (nivolumab) on September 14, 2021 at 5:00PM EST

  • Disease State Overview
  • Combination treatment for appropriate patients
  • Dosing and administration information, including dose adjustment guidance
  • Management of select adverse reactions
  • Support information and access services